Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBKIR.L Regulatory News (BKIR)

  • There is currently no data for BKIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Commercial Loan Portfolio

5 Feb 2015 10:30

RNS Number : 1428E
Bank of Ireland(Governor&Co)
05 February 2015
 



The Governor and Company of the Bank of Ireland ('Bank of Ireland')

 

Acquisition of Performing Commercial Loan Portfolio

___________________________________________________________________________

 

Bank of Ireland and Goldman Sachs have agreed terms to acquire a commercial loan portfolio of face value €540m from Danske Bank A/S. As part of the transaction, Bank of Ireland will acquire a €274m portfolio of performing commercial loans, comprising over 1,000 customers in the SME, Agriculture and CRE sectors. Goldman Sachs in conjunction with Pepper Asset Servicing, as servicer, will acquire the balance of the portfolio. The transaction is expected to close shortly.

 

Mr Mark Cunningham, Director of Bank of Ireland Business Banking commented "Bank of Ireland is pleased to have been able to avail of this opportunity to demonstrate our ongoing focus on further growing and developing our strong position in serving the business and agri sectors in Ireland. We look forward to welcoming these new customers to Bank of Ireland and working with them as they seek to develop and grow their own businesses and enterprises".

 

 

Ends.

 

For further information please contact:

 

Bank of Ireland

Andrew Keating Group Chief Financial Officer +353 (0)766 23 5141

Mark Spain Director of Group Investor Relations +353 (0)766 23 4850

Pat Farrell Head of Group Communications +353 (0)766 23 4770

 

Forward Looking Statement

 

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934 and Section 27A of the US Securities Act of 1933 with respect to certain of the Bank of Ireland Group's (the 'Group') plans and its current goals and expectations relating to its future financial condition and performance, the markets in which it operates, and its future capital requirements. These forward-looking statements often can be identified by the fact that they do not relate only to historical or current facts. Generally, but not always, words such as 'may,' 'could,' 'should,' 'will,' 'expect,' 'intend,' 'estimate,' 'anticipate,' 'assume,' 'believe,' 'plan,' 'seek,' 'continue,' 'target,' 'goal,' 'would,' or their negative variations or similar expressions identify forward-looking statements, but their absence does not mean that a statement is not forward looking. Examples of forward-looking statements include among others, statements regarding the Group's near term and longer term future capital requirements and ratios, level of ownership by the Irish Government, loan to deposit ratios, expected impairment charges, the level of the Group's assets, the Group's financial position, future income, business strategy, projected costs, margins, future payment of dividends, the implementation of changes in respect of certain of the Group's pension schemes, estimates of capital expenditures, discussions with Irish, United Kingdom, European and other regulators and plans and objectives for future operations.

 

Such forward-looking statements are inherently subject to risks and uncertainties, and hence actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, the following: geopolitical risks, such as those associated with crises in the Middle East and increasing political tensions in respect of the Ukraine, which could potentially adversely impact the markets in which the Group operates; concerns on sovereign debt and financial uncertainties in the EU and in member countries and the potential effects of those uncertainties on the Group; general and sector specific economic conditions in Ireland, the United Kingdom and the other markets in which the Group operates; the ability of the Group to generate additional liquidity and capital as required; any capital or other assessments undertaken by regulators; property market conditions in Ireland and the United Kingdom; the potential exposure of the Group to various types of market risks, such as interest rate risk, foreign exchange rate risk, credit risk and commodity price risk; deterioration in the credit quality of the Group's borrowers and counterparties, as well as increased difficulties in relation to the recoverability of loans and other amounts due from such borrowers and counterparties, have resulted in significant increases, and could result in further significant increases, in the Group's impaired loans and impairment provisions; implications of the Personal Insolvency Act 2012 and measures introduced by the Central Bank of Ireland to address mortgage arrears on the Group's distressed debt recovery and impairment provisions; the impact on lending and other activity arising from the emerging macro prudential policies; the performance and volatility of international capital markets; the effects of the Irish Government's stockholding in the Group (through the Ireland Strategic Investment Fund) and possible changes in the level of such stockholding; the impact of downgrades in the Group's or the Irish Government's credit ratings or outlook; the stability of the Eurozone; changes in the Irish and United Kingdom banking systems; changes in applicable laws, regulations and taxes in jurisdictions in which the Group operates particularly banking regulation by the Irish and United Kingdom Governments together with implementation of the Single Supervisory Mechanism and establishment of the Single Resolution Mechanism; the exercise by regulators of powers of regulation and oversight in Ireland and the United Kingdom; the introduction of new government policies or the amendment of existing policies in Ireland or the United Kingdom; the outcome of any legal claims brought against the Group by third parties or legal or regulatory proceedings or any Irish banking inquiry more generally, that may have implications for the Group; the development and implementation of the Group's strategy, including the Group's ability to achieve net interest margin increases and cost reductions; the responsibility of the Group for contributing to compensation schemes in respect of banks and other authorised financial services firms in Ireland and the United Kingdom that may be unable to meet their obligations to customers; the inherent risk within the Group's life assurance business involving claims, as well as market conditions generally; potential further contributions to the Group sponsored pension schemes if the value of pension fund assets is not sufficient to cover potential obligations; the exposure of the Group to NAMA losses in the event that NAMA has an underlying loss at the conclusion of its operations, which could adversely impact the Group's capital and results of operations; the impact of the continuing implementation of significant regulatory developments such as Basel III, Capital Requirements Directive (CRD) IV, Solvency II and the Recovery and Resolution Directive; and the Group's ability to address weaknesses or failures in its internal processes and procedures including information technology issues and equipment failures and other operational risks.

 

Nothing in this document should be considered to be a forecast of future profitability or financial position and none of the information in this document is or is intended to be a profit forecast or profit estimate. Any forward-looking statement speaks only as at the date it is made. The Group does not undertake to release publicly any revision to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date hereof. The reader should however, consult any additional disclosures that the Group has made or may make in documents filed or submitted or may file or submit to the US Securities and Exchange Commission.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQTAMMTMBBMBRA
Date   Source Headline
1st Dec 20083:47 pmBUSShort Selling Disclosure
1st Dec 200810:38 amBUSShort Selling Disclosure
28th Nov 20085:18 pmRNSB & W plc Interim Results
28th Nov 20084:40 pmRNSSecond Price Monitoring Extn
28th Nov 20084:35 pmRNSPrice Monitoring Extension
27th Nov 20089:47 amBUSShort Selling Disclosure
26th Nov 20089:39 amBUSShort Selling Disclosure
25th Nov 20084:44 pmRNSSecond Price Monitoring Extn
25th Nov 20084:38 pmRNSPrice Monitoring Extension
25th Nov 20089:27 amBUSShort Selling Disclosure
24th Nov 20081:38 pmRNSNotification of Major Intersts in Shares
24th Nov 200810:24 amBUSShort Selling Disclosure
21st Nov 200811:15 amRNSResponse to Press Comment
21st Nov 200810:27 amBUSShort Selling Disclosure
20th Nov 200810:22 amBUSShort Selling Disclosure
19th Nov 20089:32 amBUSShort Selling Disclosure
18th Nov 20084:46 pmRNSCall Option
18th Nov 20089:45 amBUSShort Selling Disclosure
17th Nov 20084:45 pmRNSSecond Price Monitoring Extn
17th Nov 20084:37 pmRNSPrice Monitoring Extension
17th Nov 200812:05 pmRNSDirector/PDMR Shareholding
17th Nov 200810:00 amBUSShort Selling Disclosure
14th Nov 200810:07 amBUSShort Selling Disclosure
13th Nov 20082:42 pmBUSShort Selling Disclosure
13th Nov 200810:00 amBUSShort Selling Disclosure
13th Nov 20087:00 amRNSInterim Results
12th Nov 20084:44 pmRNSSecond Price Monitoring Extn
12th Nov 20084:39 pmRNSPrice Monitoring Extension
27th Oct 20084:48 pmRNSSecond Price Monitoring Extn
27th Oct 20084:39 pmRNSPrice Monitoring Extension
27th Oct 200812:34 pmRNSGovernment Guarantee
21st Oct 20084:02 pmRNSMajor Interest Notification
17th Oct 20084:41 pmRNSSecond Price Monitoring Extn
17th Oct 20084:37 pmRNSPrice Monitoring Extension
14th Oct 20082:50 pmRNSShort Selling Disclosure
8th Oct 20085:33 pmRNSCall Option XS0314450437
8th Oct 200812:10 pmRNSShort Selling Disclosure
7th Oct 20085:10 pmRNSNotification of Major Interests in shares
7th Oct 20082:26 pmRNSShort Selling Disclosure
6th Oct 20082:32 pmRNSShort Selling Disclosure
3rd Oct 20084:07 pmRNSShort Selling Disclosure
3rd Oct 20083:19 pmRNSShort Selling Disclosure
2nd Oct 20083:46 pmRNSShort Selling Disclosure
1st Oct 20084:17 pmRNSTotal Voting Rights - Replacement
1st Oct 200811:16 amRNSTotal Voting Rights
30th Sep 20081:48 pmRNSBlocklisting Six Monthly Return
29th Sep 20084:04 pmRNSShort Selling Disclosure
29th Sep 200812:11 pmRNSShort Selling Disclosure
25th Sep 20085:22 pmRNSShort Selling Disclosure
24th Sep 20082:37 pmRNSShort Selling Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.